Allen Jones News
-
Paintings by Jean-Michel Basquiat, Peter Doig and Gerhard Richter starred in a $127 million sale as the auction market for contemporary art continued to grow.
-
A whistle-blower who sued Johnson & Johnson over the marketing of its antipsychotic Risperdal told a jury he was fired after probing company payments to a top pharmacist in Pennsylvania’s government who hid the money.
-
Ma Sin-chi, a Deutsche Bank AG managing director in Hong Kong, was charged with accepting HK$24.8 million ($3.2 million) in bribes in exchange for advice on the trading of derivative warrants issued by the bank.
-
Johnson & Johnson agreed to pay $158 million to settle Texas officials’ claims that the drugmaker fraudulently marketed its Risperdal anti-psychotic drug, ending a trial over the allegations.
-
Royal Bank of Scotland Group Plc’s interest-rate traders were seated with one of the main rate setters in its London office to share information, and discussed rates on conference calls, a fired trader said.
-
London’s Royal Academy was founded in 1768, a few years before the U.S. Declaration of Independence. Nonetheless, it has been edging into the 21st century.
-
Johnson & Johnson and the state of Texas won court approval of the company’s agreement to pay $158 million to settle claims that the drugmaker fraudulently marketed its Risperdal anti-psychotic drug.
-
Johnson & Johnson should reimburse at least $579 million to the Texas Medicaid system for fraudulently promoting its antipsychotic drug Risperdal for uses not approved by U.S. regulators, a state lawyer told jurors.
-
Johnson & Johnson, which has lost judgments of almost $660 million over the marketing of its antipsychotic drug Risperdal, began a trial today in which Texas is seeking damages of more than $1 billion.
-
Goldman Sachs Group Inc. persuaded a judge to dismiss Overstock.com Inc.’s lawsuit alleging the investment bank manipulated short sales of the online retailer’s stock from 2005 to 2007, causing the shares to fall.
|
|
Most Popular on Bloomberg
|
| |
Rate this Page